Ajanta Pharma Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹217.64 billion
- Book Value:
- Revenue TTM:
- ₹38.13 billion
- Operating Margin TTM:
- Gross Profit TTM:
- ₹26.92 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Ajanta Pharma Limited had its IPO on under the ticker symbol AJANTPHARM.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Ajanta Pharma Limited has a staff strength of 7,713 employees.
Shares of Ajanta Pharma Limited opened at ₹1735.2 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1700 - ₹1755, and closed at ₹1715.7.
This is a -0.74% slip from the previous day's closing price.
A total volume of 57,955 shares were traded at the close of the day’s session.
In the last one week, shares of Ajanta Pharma Limited have slipped by -0.22%.
Ajanta Pharma Limited's Key Ratios
Ajanta Pharma Limited has a market cap of ₹217.64 billion, indicating a price to book ratio of 4.3686 and a price to sales ratio of 4.4707.
In the last 12-months Ajanta Pharma Limited’s revenue was ₹38.13 billion with a gross profit of ₹26.92 billion and an EBITDA of ₹8.34 billion. The EBITDA ratio measures Ajanta Pharma Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Ajanta Pharma Limited’s operating margin was 18.82% while its return on assets stood at 9.47% with a return of equity of 17.68%.
In Q2, Ajanta Pharma Limited’s quarterly earnings growth was a positive 21.3% while revenue growth was a positive 7.4%.
Ajanta Pharma Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹48.74 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Ajanta Pharma Limited’s profitability.
Ajanta Pharma Limited stock is trading at a EV to sales ratio of 4.28 and a EV to EBITDA ratio of 15.2905. Its price to sales ratio in the trailing 12-months stood at 4.4707.
Ajanta Pharma Limited stock pays annual dividends of ₹7 per share, indicating a yield of 0.58% and a payout ratio of 34.84%.
Balance sheet and cash flow metrics
- Total Assets
- ₹46.79 billion
- Total Liabilities
- ₹11.39 billion
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Ajanta Pharma Limited ended 2023 with ₹46.79 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹46.79 billion while shareholder equity stood at ₹33.88 billion.
Ajanta Pharma Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹11.39 billion in other current liabilities, 252700000.00 in common stock, ₹33.63 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹3.30 billion and cash and short-term investments were ₹8.44 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹12.50 million.
Ajanta Pharma Limited’s total current assets stands at ₹28.25 billion while long-term investments were ₹0 and short-term investments were ₹5.13 billion. Its net receivables were ₹10.57 billion compared to accounts payable of ₹4.23 billion and inventory worth ₹8.16 billion.
In 2023, Ajanta Pharma Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Ajanta Pharma Limited paid ₹0.35 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Ajanta Pharma Limited stock is currently trading at ₹1715.7 per share. It touched a 52-week high of ₹1804.7 and a 52-week low of ₹1804.7. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1619.96 and 200-day moving average was ₹1341.22 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6644.4% of the company’s stock are held by insiders while 2240.8% are held by institutions.
Frequently Asked Questions About Ajanta Pharma Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, diabetic, cardiology, gynecology, respiratory and general health products, dermatology, and pain management areas. It also provides tablets, capsules, powder, liquid, jelly, ointments, eye drops, active pharma ingredient. The company serves in India, Africa, rest of Asia, the United States, and internationally. The company was founded in 1973 and is headquartered in Mumbai, India.